Clients who have this disorder may have an increased risk of lipid and glucose metabolism disorders.

The client's human chorionic gonadotropin (hCG) levels will plateau in the first trimester of pregnancy.

Thyroid replacement dosing will likely remain consistent throughout the pregnancy.

Antenatal fetal surveillance will be required during the first trimester of pregnancy.